Cargando…
Clinical Use of Intravenous Fosfomycin in Critical Care Patients in Taiwan
This retrospective study aimed to evaluate the clinical use and side effects of fosfomycin in critically ill patients in Taiwan. Forty-two patients (mean age, 69.9 years; female, 69%) who received fosfomycin were included from a teaching hospital in Taiwan from January 2021 to December 2021. We anal...
Autores principales: | Chen, Tzu-Ting, Chang, Yun-Fu, Wu, Yea-Chwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301606/ https://www.ncbi.nlm.nih.gov/pubmed/37375531 http://dx.doi.org/10.3390/pathogens12060841 |
Ejemplares similares
-
Fosfomycin: the characteristics, activity, and use in critical care
por: Hashemian, Seyed Mohammad Reza, et al.
Publicado: (2019) -
Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae
por: Mukherjee, DN, et al.
Publicado: (2015) -
Prevalence of fosfomycin resistance and gene mutations in clinical isolates of methicillin-resistant Staphylococcus aureus
por: Lee, Yi-Chien, et al.
Publicado: (2020) -
Oral and intravenous fosfomycin in complicated urinary tract infections
por: López-Montesinos, Inmaculada, et al.
Publicado: (2019) -
Population pharmacokinetic modeling of multiple-dose intravenous fosfomycin in critically ill patients during continuous venovenous hemodialysis
por: Hüppe, Tobias, et al.
Publicado: (2023)